Joint Formulary & PAD

Minocycline - Acne

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Minocycline
Indication :
Acne
Group Name :
Keywords :
NHS England Low Value Medicines, do not prescribe, LVM, antibiotic, antibacterial, tetracycline,
Brand Names Include :
Acnamino, Minocin MR, Aknemin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Other Indications

Below are listed other indications that Minocycline is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Acne.

Committee Recommendations (2)

At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.

If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.

The Surrey & North West Sussex Area Prescribing Committee (APC) does not recommend minocycline as a treatment option for acne and a BLACK traffic light status is recommended. (NB: Not recommended for use in any health setting across Surrey and NW Sussex health economy)

See policy statement below for more information and key references.